본문 바로가기
KERD
논문KCI 등재

Neuroprotective Effects of GV1001 in Animal Stroke Model and Neural Cells Subject to Oxygen- Glucose Deprivation/Reperfusion Injury

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류신경과학

초록

Background and Purpose Previous studies have revealed the diverse neuroprotective effects of GV1001. In this study, we investigated the effects of GV1001 on focal cerebral ischemia-reperfusion injury (IRI) in rats and oxygen-glucose deprivation/reoxygenation (OGD/R)-induced injury in neural stem cells (NSCs) and cortical neurons. Methods Focal cerebral IRI was induced by transient middle cerebral artery occlusion (MCAO). Brain diffusion-weighted imaging (DWI) was performed 2 hours after occlusion, and a total of 37 rats were treated by reperfusion with GV1001 or saline 2 hours after occlusion. Fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging, immunohistochemistry, and neurobehavioral function analyses were performed. Additionally, OGD/R-injured NSCs and cortical neurons were treated with different GV1001 concentrations. Cell viability, proliferation, migration, and oxidative stress were determined by diverse molecular analyses. Results In the stroke model, GV1001 protected neural cells against IRI. The most effective dose of GV1001 was 60 μM/kg. The infarct volume on FLAIR 48 hours after MCAO compared to lesion volume on DWI showed a significantly smaller ratio in the GV1001-treated group. GV1001-treated rats exhibited better behavioral functions than the saline-treated rats. Treatment with GV1001 increased the viability, proliferation, and migration of the OGD/R-injured NSCs. Free radicals were significantly restored by treatment with GV1001. These neuroprotective effects of GV1001 have also been demonstrated in OGD/R-injured cortical neurons. Conclusions The results suggest that GV1001 has neuroprotective effects against IRI in NSCs, cortical neurons, and the rat brain. These effects are mediated through the induction of cellular proliferation, mitochondrial stabilization, and anti-apoptotic, anti-aging, and antioxidant effects.

Abstract

Background and Purpose Previous studies have revealed the diverse neuroprotective effects of GV1001. In this study, we investigated the effects of GV1001 on focal cerebral ischemia-reperfusion injury (IRI) in rats and oxygen-glucose deprivation/reoxygenation (OGD/R)-induced injury in neural stem cells (NSCs) and cortical neurons. Methods Focal cerebral IRI was induced by transient middle cerebral artery occlusion (MCAO). Brain diffusion-weighted imaging (DWI) was performed 2 hours after occlusion, and a total of 37 rats were treated by reperfusion with GV1001 or saline 2 hours after occlusion. Fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging, immunohistochemistry, and neurobehavioral function analyses were performed. Additionally, OGD/R-injured NSCs and cortical neurons were treated with different GV1001 concentrations. Cell viability, proliferation, migration, and oxidative stress were determined by diverse molecular analyses. Results In the stroke model, GV1001 protected neural cells against IRI. The most effective dose of GV1001 was 60 μM/kg. The infarct volume on FLAIR 48 hours after MCAO compared to lesion volume on DWI showed a significantly smaller ratio in the GV1001-treated group. GV1001-treated rats exhibited better behavioral functions than the saline-treated rats. Treatment with GV1001 increased the viability, proliferation, and migration of the OGD/R-injured NSCs. Free radicals were significantly restored by treatment with GV1001. These neuroprotective effects of GV1001 have also been demonstrated in OGD/R-injured cortical neurons. Conclusions The results suggest that GV1001 has neuroprotective effects against IRI in NSCs, cortical neurons, and the rat brain. These effects are mediated through the induction of cellular proliferation, mitochondrial stabilization, and anti-apoptotic, anti-aging, and antioxidant effects.

참고문헌 (32)

  1. Simone Vidale, "Postischemic Inflammation in Acute Stroke", Journal of Clinical Neurology, 13(1), pp.1~9 (2017), 대한신경과학회[DOI]
  2. Jung JE, "Reperfusion and neurovascular dysfunction in stroke : from basic mechanisms to potential strategies for neuroprotection", Mol Neurobiol, 41, pp.172~179 (2010)
  3. Park HH, "Neural stem cells injured by oxidative stress can be rejuvenated by GV1001, a novel peptide, through scavenging free radicals and enhancing survival signals", Neurotoxicology, 55, pp.131~141 (2016)
  4. Martínez P, "Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins", Nat Rev Cancer, 11, pp.161~176 (2011)
  5. Park HH, "Novel vaccine peptide GV1001 effectively blocks β-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase", Neurobiol Aging, 35, pp.1255~1274 (2014)
  6. Ko YJ, "The anti-inflammatory effect of human telomerase-derived peptide on P. gingivalis lipopolysaccharide-induced inflammatory cytokine production and its mechanism in human dental pulp cells", Mediators Inflamm, 2015, pp.385127~ (2015)
  7. Koh SH, "The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals", Eur J Neurosci, 20, pp.1461~1472 (2004)
  8. Koh SH, "Inhibition of GSK-3 reduces infarct volume and improves neurobehavioral functions", Biochem Biophys Res Commun, 371, pp.894~899 (2008)
  9. Kim YS, "Early activation of phosphatidylinositol 3-kinase after ischemic stroke reduces infarct volume and improves long-term behavior", Mol Neurobiol, 54, pp.5375~5384 (2017)
  10. Chen J, "Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats", Stroke, 32, pp.1005~1011 (2001)
  11. Sughrue ME, "An improved test of neurological dysfunction following transient focal cerebral ischemia in rats", J Neurosci Methods, 151, pp.83~89 (2006)
  12. Studer L, "Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats", Nat Neurosci, 1, pp.290~295 (1998)
  13. Currle DS, "Culture of mouse neural stem cell precursors", J Vis Exp, 2, pp.152~ (2007)
  14. Koo TY, "Protective effect of peptide GV1001against renal ischemia-reperfusion injury in mice", Transplant Proc, 46, pp.1117~1122 (2014)
  15. Kyte JA, "Cancer vaccination with telomerase peptide GV1001", Expert Opin Investig Drugs, 18, pp.687~694 (2009)
  16. Lee YK, "Protective effect of telomerase-based 16-mer peptide vaccine(GV1001)on inferior epigastric island skin flap survivability in ischaemia-reperfusion injury rat model", J Plast Surg Hand Surg, 51, pp.210~216 (2017)
  17. Chang JE, "Protective effects of GV1001 on myocardial ischemia‑reperfusion injury", Mol Med Rep, 16, pp.7315~7320 (2017)
  18. Chang JE, "Reduction of ischaemiareperfusion injury in a rat lung transplantation model by lowconcentration GV1001", Eur J Cardiothorac Surg, 50, pp.972~979 (2016)
  19. Son JW, "Activation of the phosphatidylinositol 3-kinase pathway plays important roles in reduction of cerebral infarction by cilnidipine", J Neurochem, 135, pp.186~193 (2015)
  20. Pap M, "Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase", Akt, Mol Cell Biol, pp.2002, 22[DOI]
  21. Hemmings BA, "The PI3K-PKB", Akt pathway, 2015, pp.7, a026609~
  22. Song WJ, "Phosphorylation and inactivation of glycogen synthase kinase 3β(GSK3β)by dual-specificity tyrosine phosphorylation-regulated kinase 1A(Dyrk1A)", J Biol Chem, 290, pp.2321~2333 (2015)
  23. Yamaguchi H, "The protein kinase PKB", Akt regulates cell survival and apoptosis by inhibiting Bax conformational change, 2001, pp.20, 7779~7786
  24. Xie C, "EEF1D promotes glioma proliferation, migration, and invasion through EMT and PI3K", Akt pathway, 2020, pp.2020, 7804706~
  25. Hemmings BA, "PI3K-PKB", Akt pathway, 2012, pp.4, a011189~
  26. Quan C, "Ezrin promotes pancreatic cancer cell proliferation and invasion through activating the Akt", mTOR pathway and inducing YAP translocation, 2019, pp.11, 6553~6566
  27. Koh SH, "Neurogenesis in stroke recovery", Transl Stroke Res, 8, pp.3~13 (2017)
  28. Shuai Zhang, "Optimizing Stem Cell Therapy after Ischemic Brain Injury", 대한뇌졸중학회지, 22(3), pp.286~305 (2020), 대한뇌졸중학회
  29. Ellis P, "SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult", Dev Neurosci, 26, pp.148~165 (2004)
  30. Wei ZZ, "Neuroprotective and regenerative roles of intranasal Wnt-3a administration after focal ischemic stroke in mice", J Cereb Blood Flow Metab, 38, pp.404~421 (2018)
  31. Richardsen E, "Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort", PLoS One, 12, pp.e0186852~ (2017)
  32. Lange SS, "High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage", Proc Natl Acad Sci U S A, 105, pp.10320~10325 (2008)

관련 논문AI추천

Neuroprotectants in the Era of Reperfusion TherapyÁngel Chamorro대한뇌졸중학회 · 대한뇌졸중영문학회지2018 · 제20권 제2호Supra-Additive Neuroprotection by Renexin, a Mixed Compound of Ginkgo Biloba Extract and Cilostazol, Against Apoptotic White Matter Changes in Rat after Chronic Cerebral Hypoperfusion곽필애, 김영인, 손영민, 임성철, 한시령대한신경과학회 · Journal of Clinical Neurology2012 · 제8권 제4호Protective effects of Tat-NQO1 against oxidative stress-induced HT-22 cell damage, and ischemic injury in animals김대원, 김덕수, 박정환, 박진서, 신민재, 안은희, 여은지, 음원식, 이치헌, 정석영, 조성우, 조수빈, 조효상, 최수영, 최연주, 한규형, Hyeon Ji Yeo생화학분자생물학회 · BMB Reports2016 · 제49권 제11호Neuroprotective effects of the antioxidant action of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride against ischemic neuronal damage in the brain김대원, 김덕수, 김은아, 조성우, 최수영, 하성철, 한아름생화학분자생물학회 · BMB Reports2013 · 제46권 제7호Neuroprotective Effects of Guh-Poong-Chung-Sim-Hwan on Focal Cerebral Ischemia in Rats김정범, 임하섭한의병리학회 · 동의생리병리학회지2005 · 제19권 제1호Primary astrocytic mitochondrial transplantation ameliorates ischemic stroke이민형, Chang-Hwan Park, Chun-Hyung Kim, Eun-Hye Lee, Minkyung Kim, Seung Hwan Ko생화학분자생물학회 · BMB Reports2023 · 제56권 제2호

이 간행물의 다른 논문 (14건)